Treating obesity: a new target for prevention of coronary heart disease.
- 8 June 2001
- journal article
- review article
- Published by Wiley in Progress in Cardiovascular Nursing
- Vol. 16 (3) , 98-115
- https://doi.org/10.1111/j.0889-7204.2001.00589.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Absence of Cardiac Valve Dysfunction in Obese Patients Treated with SibutramineObesity Research, 1999
- Drug Therapy for Obesity--A Therapeutic Option?Journal of Clinical Endocrinology & Metabolism, 1999
- Modern Medical Management of Obesity: The Role of Pharmaceutical InterventionJournal of the American Dietetic Association, 1998
- What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes.Journal of Consulting and Clinical Psychology, 1997
- Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of ObesityPublished by American Medical Association (AMA) ,1996
- Current views on obesityThe American Journal of Medicine, 1996
- Sibutramine: A Novel New Agent for Obesity TreatmentObesity Research, 1995
- A Prospective Study of Obesity and Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1990
- Obesity, Weight Loss and Prognosis in Type 2 DiabetesDiabetic Medicine, 1990
- Relation of weight change to changes in atherogenic traits: The Framingham studyJournal of Chronic Diseases, 1974